Literature DB >> 28363592

A survey of critical care nurses' practices and perceptions surrounding early intravenous antibiotic initiation during septic shock.

Russel J Roberts1, Abdullah M Alhammad2, Lindsay Crossley3, Eric Anketell4, LeeAnn Wood5, Greg Schumaker6, Erik Garpestad7, John W Devlin8.   

Abstract

BACKGROUND: Delays in antibiotic administration after severe sepsis recognition increases mortality. While physician and pharmacy-related barriers to early antibiotic initiation have been well evaluated, those factors that affect the speed by which critical care nurses working in either the emergency department or the intensive care unit setting initiate antibiotic therapy remains poorly characterized. AIM: To evaluate the knowledge, practices and perceptions of critical care nurses regarding antibiotic initiation in patients with newly recognised septic shock.
METHODS: A validated survey was distributed to 122 critical care nurses at one 320-bed academic institution with a sepsis protocol advocating intravenous(IV) antibiotic initiation within 1hour of shock recognition.
RESULTS: Among 100 (82%) critical care nurses responding, nearly all (98%) knew of the existence of the sepsis protocol. However, many critical care nurses stated they would optimise blood pressure [with either fluid (38%) or both fluid and a vasopressor (23%)] before antibiotic initiation. Communicated barriers to rapid antibiotic initiation included: excessive patient workload (74%), lack of awareness IV antibiotic(s) ordered (57%) or delivered (69%), need for administration of multiple non-antibiotic IV medications (54%) and no IV access (51%).
CONCLUSIONS: Multiple nurse-related factors influence IV antibiotic(s) initiation speed and should be incorporated into sepsis quality improvement efforts.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic; Barriers; Intensive care; Nurse; Nursing; Quality improvement; Sepsis; Septic shock

Mesh:

Substances:

Year:  2017        PMID: 28363592     DOI: 10.1016/j.iccn.2017.02.002

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  6 in total

1.  An Interprofessional Approach to Clinical Workflow Evaluation Focused on the Electronic Health Record Using Time motion Study Methods.

Authors:  Jessica Schwartz; Jonathan Elias; Cody Slater; Kenrick Cato; Sarah Collins Rossetti
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

2.  Leveraging Clinical Expertise as a Feature - not an Outcome - of Predictive Models: Evaluation of an Early Warning System Use Case.

Authors:  Sarah Collins Rossetti; Chris Knaplund; Dave Albers; Abdul Tariq; Kui Tang; David Vawdrey; Natalie H Yip; Patricia C Dykes; Jeffrey G Klann; Min Jeoung Kang; Jose Garcia; Li-Heng Fu; Kumiko Schnock; Kenrick Cato
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

3.  Association of Registered Nurse Staffing With Mortality Risk of Medicare Beneficiaries Hospitalized With Sepsis.

Authors:  Jeannie P Cimiotti; Edmund R Becker; Yin Li; Douglas M Sloane; Scott K Fridkin; Anna Beth West; Linda H Aiken
Journal:  JAMA Health Forum       Date:  2022-05-27

4.  25 × 5 Symposium to Reduce Documentation Burden: Report-out and Call for Action.

Authors:  Mollie Hobensack; Deborah R Levy; Kenrick Cato; Don E Detmer; Kevin B Johnson; Jeffrey Williamson; Judy Murphy; Amanda Moy; Jennifer Withall; Rachel Lee; Sarah Collins Rossetti; Samuel Trent Rosenbloom
Journal:  Appl Clin Inform       Date:  2022-05-11       Impact factor: 2.762

5.  Early fluid bolus in adults with sepsis in the emergency department: a systematic review, meta-analysis and narrative synthesis.

Authors:  Gladis Kabil; Steven A Frost; Deborah Hatcher; Amith Shetty; Jann Foster; Stephen McNally
Journal:  BMC Emerg Med       Date:  2022-01-11

6.  Sepsis assessment and management in critically Ill adults: A systematic review.

Authors:  Mohammad Rababa; Dania Bani Hamad; Audai A Hayajneh
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.